|
2012 Conference Publication L-arginine depletion by PEG-arginase I, a new potential therapy for acute lymphoblastic leukemiaRamos, Ofelia Crombet, Hernandez, Claudia, Morrow, Kevin, Cole, John T. and Rodriguez, Paulo (2012). L-arginine depletion by PEG-arginase I, a new potential therapy for acute lymphoblastic leukemia. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2011 Conference Publication B12 DEFICIENCY REVISITEDJahangir, K. S., Varughese, S., Lin, T. L., Boulmay, B. C., Rigby, P. G. and Cole, J. T. (2011). B12 DEFICIENCY REVISITED. Southern Regional Meeting, New Orleans La, Feb 17-19, 2011. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2011 Conference Publication MY COLLAR BONE HURTS!Varughese, S., Jahangir, K. S., Lin, T., Boulmay, B., Rigby, P. and Cole, J. T. (2011). MY COLLAR BONE HURTS!. Southern Regional Meeting, New Orleans La, Feb 17-19, 2011. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2009 Conference Publication Prelinical Evaluation of Lyn Kinase Inhibition for the Treatment of B Cell Chronic Lymphocytic Leukemia (B-CLL)Velcheti, Vamsidhar, Li, Li, Philips, Joseph, Fuloria, Jyotsna, Rodwig, Francis R., Cole, John T., Samaniego, Felipe and Prakash, Om (2009). Prelinical Evaluation of Lyn Kinase Inhibition for the Treatment of B Cell Chronic Lymphocytic Leukemia (B-CLL). 51st Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 05-08, 2009. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2008 Conference Publication Protein Kinase C-Epsilon Is An Important Component of the Lyn Kinase Signaling Pathway in the Apoptotic Resistance of B-Chronic Lymphocytic Leukemia CellsVelcheti, Vamsidhar, Tamma, Srikanth, Larned, Zoe L., Fuloria, Jyotsna, Li, Li, Rodwig, Francis R., Cole, John T., Samaniego, Felipe and Prakash, Om (2008). Protein Kinase C-Epsilon Is An Important Component of the Lyn Kinase Signaling Pathway in the Apoptotic Resistance of B-Chronic Lymphocytic Leukemia Cells. 50th Annual Meeting of the American-Society-of-Hematology, San Francisco Ca, Dec 06-09, 2008. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2008 Conference Publication Differences in treatment and outcomes of non-small cell lung cancer (NSCLC) in Louisiana compared to the rest of the United States: A National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) analysisVelcheti, V., Thumma, V., Matrana, M. and Cole, J. T. (2008). Differences in treatment and outcomes of non-small cell lung cancer (NSCLC) in Louisiana compared to the rest of the United States: A National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) analysis. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2008.26.15_suppl.17507 |
|
1988 Conference Publication Phase-I Study of Deoxycytidine Administered as a 120 Hour Continuous Intravenous-InfusionBhalla, K., Grant, S., Maclaughlin, W., Cole, J., Birkhofer, M., Kappel, B., Kritz, A. and Graham, G. (1988). Phase-I Study of Deoxycytidine Administered as a 120 Hour Continuous Intravenous-Infusion. -, -, -. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. |
|
1988 Conference Publication Continuously Administered 2',2'-Difluorodeoxycytidine (Dfdc) and Deoxycytidine (Dcyd) - a Potentially Selective Cyto-Toxic Regimen Toward Human-Leukemic Myeloid Progenitors in CultureBhalla, K., Maclaughlin, W., Cole, J., Arlin, Z., Birkhofer, M. and Graham, G. (1988). Continuously Administered 2',2'-Difluorodeoxycytidine (Dfdc) and Deoxycytidine (Dcyd) - a Potentially Selective Cyto-Toxic Regimen Toward Human-Leukemic Myeloid Progenitors in Culture. -, -, -. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. |
|
1987 Conference Publication High-Dose of Deoxycytidine Analogs and Deoxycytidine - a Potentially Selective Cytotoxic Regimen Against Breast-Cancer Cells (47D) in CultureMacLaughlin, W., Cole, J., Grant, S. and Bhalla, K. (1987). High-Dose of Deoxycytidine Analogs and Deoxycytidine - a Potentially Selective Cytotoxic Regimen Against Breast-Cancer Cells (47D) in Culture. -, -, -. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. |
|
1987 Conference Publication Mechanism Underlying the Selective Cytotoxicity of High-Dose Ara-C and Deoxycytidine Toward Human-Leukemic Myeloid Progenitor CellsBhalla, K., Maclaughlin, W., Cole, J., Arlin, Z., Baker, M., Graham, G. and Grant, S. (1987). Mechanism Underlying the Selective Cytotoxicity of High-Dose Ara-C and Deoxycytidine Toward Human-Leukemic Myeloid Progenitor Cells. -, -, -. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. |
|
1986 Conference Publication Differential Reversal of Deoxycytidine Analog Mediated Cytotoxicity by Deoxycytidine in Cultured Normal and Leukemic Myeloid ProgenitorsMacLaughlin, W., Bhalla, K., Cole, J. and Grant, S. (1986). Differential Reversal of Deoxycytidine Analog Mediated Cytotoxicity by Deoxycytidine in Cultured Normal and Leukemic Myeloid Progenitors. -, -, -. THOROFARE: SLACK INC. |
|
1986 Conference Publication Continuously Administered High-Dose Ara-C and Deoxycytidine - a Potentially Selective Cytotoxic Regimen Toward Human-Leukemic Myeloid Progenitors in CultureBhalla, K., Maclaughlin, W., Cole, J., Arlin, Z., Baker, M., Graham, G. and Grant, S. (1986). Continuously Administered High-Dose Ara-C and Deoxycytidine - a Potentially Selective Cytotoxic Regimen Toward Human-Leukemic Myeloid Progenitors in Culture. -, -, -. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. |
